Applications of endoscopic ultrasound in pancreatic cancer

World Journal of Gastroenterology

Volumn 20, Issue 24, 2014, Pages 7808-7818

  Luz, Leticia Perondi ^a   Al Haddad, Mohammad Ali ^a   Sey, Michael Sai Lai ^a   Dewitt, John M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Endoscopic ultrasound guided fine needle aspiration; Endoscopic ultrasound guided fine needle aspiration; Endosonography; Pancreatic ductal carcinoma; Pancreatic neoplasm

Indexed keywords

FLUOROURACIL; GOLNERMINOGENE PRADENOVEC; IODINE 125; K RAS PROTEIN; MORPHINE; PERFLUBUTANE; SHU 508; SONOVUE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BILIARY TRACT DRAINAGE; CANCER DIAGNOSIS; CANCER STAGING; CELIAC PLEXUS; CHRONIC PANCREATITIS; CONTROLLED CLINICAL TRIAL (TOPIC); DIAGNOSTIC ACCURACY; DNA MARKER; ELASTOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FIDUCIAL MARKER; HUMAN; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); MUTATIONAL ANALYSIS; NEUROLYSIS; PANCREAS ADENOCARCINOMA; SYSTEMATIC REVIEW (TOPIC); BRACHYTHERAPY; CARCINOMA, PANCREATIC DUCTAL; DEVICES; ECHOGRAPHY; PANCREATIC NEOPLASMS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; TREATMENT OUTCOME;

BRACHYTHERAPY; CARCINOMA, PANCREATIC DUCTAL; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; ENDOSONOGRAPHY; FIDUCIAL MARKERS; HUMANS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84903193177     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i24.7808     Document Type: Article

References (113)

1. Vilmann P, Jacobsen GK, Henriksen FW, Hancke S. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc 1992; 38: 172-173.[PMID: 1568614]
2. Lin JT, Wang JT, Wang TH. The diagnostic value of endoscopic ultrasonography in pancreatic disorders. Taiwan Yi Xue Hui Za Zhi 1989; 88: 483-487.[PMID: 2677230]
3. Rösch T, Lorenz R, Braig C, Feuerbach S, Siewert JR, Schusdziarra V, Classen M. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 1991; 37: 347-352.[PMID: 2070987]
4. Rösch T, Braig C, Gain T, Feuerbach S, Siewert JR, Schusdzi-arra V, Classen M. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992; 102: 188-199.[PMID: 1727753]
5. Palazzo L, Roseau G, Gayet B, Vilgrain V, Belghiti J, Fékéte F, Paolaggi JA. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993; 25: 143-150.[PMID: 8491130]
6. Müller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190: 745-751.[PMID: 8115622]
7. Sugiyama M, Hagi H, Atomi Y, Saito M. Diagnosis of portalvenous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography. Abdom Imaging 1997; 22: 434-438.[PMID: 9157867]
8. Gress FG, Hawes RH, Savides TJ, Ikenberry SO, Cummings O, Kopecky K, Sherman S, Wiersema M, Lehman GA. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 1999; 50: 786-791.[PMID: 10570337]
9. Ainsworth AP, Rafaelsen SR, Wamberg PA, Durup J, Pless TK, Mortensen MB. Is there a difference in diagnostic accuracy and clinical impact between endoscopic ultrasonography and magnetic resonance cholangiopancreatography? Endoscopy 2003; 35: 1029-1032.[PMID: 14648416 DOI: 10.1055/ s-2003-44603]
10. Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 2004; 99: 844-850.[PMID: 15128348 DOI:10.1111/j.1572-0241.2004.04177.x]
11. DeWitt J, Devereaux B, Chriswell M, McGreevy K, Howard T, Imperiale TF, Ciaccia D, Lane KA, Maglinte D, Kopecky K, LeBlanc J, McHenry L, Madura J, Aisen A, Cramer H, Cum mings O, Sherman S. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004; 141: 753-763.[PMID: 15545675]
12. Wang W, Shpaner A, Krishna SG, Ross WA, Bhutani MS,Tamm EP, Raju GS, Xiao L, Wolff RA, Fleming JB, Lee JH. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT. Gastrointest Endosc 2013; 78: 73-80.[PMID: 23523302 DOI: 10.1016/j.gie.2013.01.040]
13. Bhutani MS, Gress FG, Giovannini M, Erickson RA, Cata-lano MF, Chak A, Deprez PH, Faigel DO, Nguyen CC. The No Endosonographic Detection of Tumor (NEST) Study: a case series of pancreatic cancers missed on endoscopic ultrasonography. Endoscopy 2004; 36: 385-389.[PMID: 15100944 DOI: 10.1055/s-2004-814320]
14. Catanzaro A, Richardson S, Veloso H, Isenberg GA, Wong RC, Sivak MV, Chak A. Long-term follow-up of patients with clinically indeterminate suspicion of pancreatic cancer and normal EUS. Gastrointest Endosc 2003; 58: 836-840.[PMID: 14652549]
15. Ranney N, Phadnis M, Trevino J, Ramesh J, Wilcox CM, Varadarajulu S. Impact of biliary stents on EUS-guided FNA of pancreatic mass lesions. Gastrointest Endosc 2012; 76: 76-83.[PMID: 22726468 DOI: 10.1016/j.gie.2012.02.049]
16. Gong TT, Hu DM, Zhu Q. Contrast-enhanced EUS for differ-ential diagnosis of pancreatic mass lesions: a meta-analysis. Gastrointest Endosc 2012; 76: 301-309.[PMID: 22703697 DOI:10.1016/j.gie.2012.02.051]
17. Ophir J, Céspedes I, Ponnekanti H, Yazdi Y, Li X. Elastog-raphy: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 1991; 13: 111-134.[PMID: 1858217]
18. Hu DM, Gong TT, Zhu Q. Endoscopic ultrasound elastogra-phy for differential diagnosis of pancreatic masses: a metaanalysis. Dig Dis Sci 2013; 58: 1125-1131.[PMID: 23306838 DOI: 10.1007/s10620-012-2428-5]
19. Mei M, Ni J, Liu D, Jin P, Sun L. EUS elastography for diag-nosis of solid pancreatic masses: a meta-analysis. Gastrointest Endosc 2013; 77: 578-589.[PMID: 23199646 DOI: 10.1016/ j.gie.2012.09.035]
20. Sǎftoiu A, Iordache SA, Gheonea DI, Popescu C, Maloş A, Gorunescu F, Ciurea T, Iordache A, Popescu GL, Manea CT. Combined contrast-enhanced power Doppler and real-time sonoelastography performed during EUS, used in the differential diagnosis of focal pancreatic masses (with videos). Gastrointest Endosc 2010; 72: 739-747.[PMID: 20674916 DOI:10.1016/j.gie.2010.02.056]
21. Hewitt MJ, McPhail MJ, Possamai L, Dhar A, Vlavianos P, Monahan KJ. EUS-guided FNA for diagnosis of solid pan-creatic neoplasms: a meta-analysis. Gastrointest Endosc 2012; 75: 319-331.[PMID: 22248600 DOI: 10.1016/j.gie.2011.08.049]
22. Hébert-Magee S, Bae S, Varadarajulu S, Ramesh J, Frost AR, Eloubeidi MA, Eltoum IA. The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasoundguided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta-analysis. Cytopathology 2013; 24: 159-171.[PMID: 23711182 DOI: 10.1111/cyt.12071]
23. Wang KX, Ben QW, Jin ZD, Du YQ, Zou DW, Liao Z, Li ZS. Assessment of morbidity and mortality associated with EUSguided FNA: a systematic review. Gastrointest Endosc 2011; 73: 283-290.[PMID: 21295642 DOI: 10.1016/j.gie.2010.10.045]
24. Micames C, Jowell PS, White R, Paulson E, Nelson R, Morse M, Hurwitz H, Pappas T, Tyler D, McGrath K. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc 2003; 58: 690-695.[PMID: 14595302]
25. Ikezawa K, Uehara H, Sakai A, Fukutake N, Imanaka K, Ohkawa K, Tanakura R, Ioka T, Tanaka S, Ishikawa O, Katayama K. Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. J Gastroenterol 2013; 48: 966-972.[PMID: 23065024 DOI:10.1007/s00535-012-0693-x]
26. Beane JD, House MG, Coté GA, DeWitt JM, Al-Haddad M, LeBlanc JK, McHenry L, Sherman S, Schmidt CM, Zyromski NJ, Nakeeb A, Pitt HA, Lillemoe KD. Outcomes after preoperative endoscopic ultrasonography and biopsy in patients undergoing distal pancreatectomy. Surgery 2011; 150: 844-853.[PMID: 22000199 DOI: 10.1016/j.surg.2011.07.068]
27. Ngamruengphong S, Xu C, Woodward TA, Raimondo M, Stauffer JA, Asbun HJ, Wallace MB. Risk of gastric or peritoneal recurrence, and long-term outcomes, following pancreatic cancer resection with preoperative endosonographically guided fine needle aspiration. Endoscopy 2013; 45: 619-626.[PMID: 23881804 DOI: 10.1055/s-0033-1344216]
28. Fritscher-Ravens A, Brand L, Knöfel WT, Bobrowski C, Topa-lidis T, Thonke F, de Werth A, Soehendra N. Comparison of endoscopic ultrasound-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis. Am J Gastroenterol 2002; 97: 2768-2775.[PMID: 12425546 DOI: 10.1111/j.1572-0241.2002.07020.x]
29. Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc 2005; 62: 728-36; quiz 751, 753.[PMID: 16246688 DOI: 10.1016/ j.gie.2005.06.051]
30. Schwartz DA, Unni KK, Levy MJ, Clain JE, Wiersema MJ. The rate of false-positive results with EUS-guided fine-needle aspiration. Gastrointest Endosc 2002; 56: 868-872.[PMID: 12447300 DOI: 10.1067/mge.2002.129610]
31. Siddiqui AA, Kowalski TE, Shahid H, O'Donnell S, Tolin J, Loren DE, Infantolino A, Hong SK, Eloubeidi MA. Falsepositive EUS-guided FNA cytology for solid pancreatic lesions. Gastrointest Endosc 2011; 74: 535-540.[PMID: 21737075 DOI: 10.1016/j.gie.2011.04.039]
32. Erickson RA, Sayage-Rabie L, Beissner RS. Factors predict-ing the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000; 51: 184-190.[PMID: 10650262]
33. LeBlanc JK, Ciaccia D, Al-Assi MT, McGrath K, Imperiale T, Tao LC, Vallery S, DeWitt J, Sherman S, Collins E. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 2004; 59: 475-481.[PMID: 15044881]
34. Madhoun MF, Wani SB, Rastogi A, Early D, Gaddam S, Tierney WM, Maple JT. The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis. Endoscopy 2013; 45: 86-92.[PMID: 23307148 DOI: 10.1055/ s-0032-1325992]
35. Affolter KE, Schmidt RL, Matynia AP, Adler DG, Factor RE. Needle size has only a limited effect on outcomes in EUSguided fine needle aspiration: a systematic review and metaanalysis. Dig Dis Sci 2013; 58: 1026-1034.[PMID: 23086117 DOI: 10.1007/s10620-012-2439-2]
36. Sakamoto H, Kitano M, Komaki T, Noda K, Chikugo T, Dote K, Takeyama Y, Das K, Yamao K, Kudo M. Prospective comparative study of the EUS guided 25-gauge FNA needle with the 19-gauge Trucut needle and 22-gauge FNA needle in patients with solid pancreatic masses. J Gastroenterol Hepatol 2009; 24: 384-390.[PMID: 19032453 DOI: 10.1111/ j.1440-1746.2008.05636.x]
37. Camellini L, Carlinfante G, Azzolini F, Iori V, Cavina M, Sereni G, Decembrino F, Gallo C, Tamagnini I, Valli R, Piana S, Campari C, Gardini G, Sassatelli R. A randomized clinical trial comparing 22G and 25G needles in endoscopic ultrasound-guided fine-needle aspiration of solid lesions. Endoscopy 2011; 43: 709-715.[PMID: 21611946 DOI: 10.1055/ s-0030-1256482]
38. Varadarajulu S, Bang JY, Hebert-Magee S. Assessment ofthe technical performance of the flexible 19-gauge EUS-FNA needle. Gastrointest Endosc 2012; 76: 336-343.[PMID: 22817786 DOI: 10.1016/j.gie.2012.04.455]
39. Ogura T, Yamao K, Sawaki A, Mizuno N, Hara K, Hijioka S, Niwa Y, Tajika M, Kondo S, Shimizu Y, Bhatia V, Higuchi K, Hosoda W, Yatabe Y. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses. Gastrointest Endosc 2012; 75: 769-774.[PMID: 22284089 DOI:10.1016/j.gie.2011.11.012]
40. Fuccio L, Hassan C, Laterza L, Correale L, Pagano N, Bocus P, Fabbri C, Maimone A, Cennamo V, Repici A, Costamagna G, Bazzoli F, Larghi A. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Gastrointest Endosc 2013; 78: 596-608.[PMID: 23660563 DOI: 10.1016/j.gie.2013.04.162]
41. Salek C, Benesova L, Zavoral M, Nosek V, Kasperova L, Ryska M, Strnad R, Traboulsi E, Minarik M. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer. World J Gastroenterol 2007; 13: 3714-3720.[PMID: 17659731]
42. Kubiliun N, Ribeiro A, Fan YS, Rocha-Lima CM, Sleeman D, Merchan J, Barkin J, Levi J. EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology results. Gastrointest Endosc 2011; 74: 541-547.[PMID: 21752364 DOI: 10.1016/j.gie.2011.04.043]
43. Ahmad NA, Lewis JD, Siegelman ES, Rosato EF, Ginsberg GG, Kochman ML. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma. Am J Gastroenterol 2000; 95: 1926-1931.[PMID: 10950037]
44. Akahoshi K, Chijiiwa Y, Nakano I, Nawata H, Ogawa Y, Tanaka M, Nagai E, Tsuneyoshi M. Diagnosis and staging of pancreatic cancer by endoscopic ultrasound. Br J Radiol 1998; 71: 492-496.[PMID: 9691893]
45. Buscail L, Pagès P, Berthélemy P, Fourtanier G, Frexinos J, Escourrou J. Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis. Gastrointest Endosc 1999; 50: 34-40.[PMID: 10385719]
46. Giovannini M, Seitz JF. Endoscopic ultrasonography witha linear-type echoendoscope in the evaluation of 94 patients with pancreatobiliary disease. Endoscopy 1994; 26: 579-585.[PMID: 8001484]
47. Grimm H, Maydeo A, Soehendra N. Endoluminal ultra-sound for the diagnosis and staging of pancreatic cancer. Baillieres Clin Gastroenterol 1990; 4: 869-888.[PMID: 2078789]
48. Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, Coste J, Louvel A, Roseau G, Couturier D, Bon-nin A. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998; 170: 1315-1322.[PMID: 9574609]
49. Midwinter MJ, Beveridge CJ, Wilsdon JB, Bennett MK, Baudouin CJ, Charnley RM. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999; 86: 189-193.[PMID: 10100785 DOI: 10.1046/ j.1365-2168.1999.01042.x]
50. Mukai H, Nakajima M, Yasuda K, Cho E, Mizuma Y, Haya-kumo T, Ashihara T, Mizuno S, Hirano S, Ikeda E. Preoperative diagnosis and staging of pancreatic cancer by endoscopic ultrasonography (EUS)--a comparative study with other diagnostic tools. Nihon Shokakibyo Gakkai Zasshi 1991; 88: 2132-2142.[PMID: 1795424]
51. Ramsay D, Marshall M, Song S, Zimmerman M, Edmunds S, Yusoff I, Cullingford G, Fletcher D, Mendelson R. Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging. Australas Radiol 2004; 48: 154-161.[PMID: 15230749 DOI: 10.1111/ j.1440-1673.2004.01277.x]
52. Rivadeneira DE, Pochapin M, Grobmyer SR, Lieberman MD, Christos PJ, Jacobson I, Daly JM. Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary malignancies. Ann Surg Oncol 2003; 10: 890-897.[PMID: 14527907]
53. Rösch T, Dittler HJ, Lorenz R, Braig C, Gain T, Feuerbach S, Höfler H, Siewert JR, Classen M. The endosonographic staging of pancreatic carcinoma. Dtsch Med Wochenschr 1992; 117: 563-569.[PMID: 1559451]
54. Soriano A, Castells A, Ayuso C, Ayuso JR, de Caralt MT, Gi-nès MA, Real MI, Gilabert R, Quintó L, Trilla A, Feu F, Montanyà X, Fernández-Cruz L, Navarro S. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 2004; 99: 492-501.[PMID: 15056091 DOI: 10.1111/j.1572-0241.2004.04087.x]
55. Tio TL, Sie LH, Kallimanis G, Luiken GJ, Kimmings AN, Huibregtse K, Tytgat GN. Staging of ampullary and pancreatic carcinoma: comparison between endosonography and surgery. Gastrointest Endosc 1996; 44: 706-713.[PMID: 8979062]
56. Tio TL, Tytgat GN, Cikot RJ, Houthoff HJ, Sars PR. Am-pullopancreatic carcinoma: preoperative TNM classification with endosonography. Radiology 1990; 175: 455-461.[PMID: 2183284]
57. Yasuda K, Mukai H, Nakajima M, Kawai K. Staging of pan-creatic carcinoma by endoscopic ultrasonography. Endoscopy 1993; 25: 151-155.[PMID: 8491131 DOI: 10.1055/s-2007-1010274]
58. Ahmad NA, Lewis JD, Ginsberg GG, Rosato EF, Morris JB, Kochman ML. EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 2000; 52: 463-468.[PMID: 11023561]
59. Bhutani MS, Hawes RH, Hoffman BJ. A comparison of theaccuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997; 45: 474-479.[PMID: 9199903]
60. Catalano MF, Sivak MV, Rice T, Gragg LA, Van Dam J. En-dosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994; 40: 442-446.[PMID: 7926534]
61. Hollerbach S, Willert J, Topalidis T, Reiser M, Schmiegel W. Endoscopic ultrasound-guided fine-needle aspiration biopsy of liver lesions: histological and cytological assessment. Endoscopy 2003; 35: 743-749.[PMID: 12929021 DOI: 10.1055/ s-2003-41593]
62. Nguyen P, Feng JC, Chang KJ. Endoscopic ultrasound (EUS)and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc 1999; 50: 357-361.[PMID: 10462656]
63. Tenberge J, Hoffman BJ, Hawes RH, Van Enckevort C, Giovannini M, Erickson RA, Catalano MF, Fogel R, Mallery S, Faigel DO, Ferrari AP, Waxman I, Palazzo L, Ben-Menachem T, Jowell PS, McGrath KM, Kowalski TE, Nguyen CC, Wassef WY, Yamao K, Chak A, Greenwald BD, Woodward TA, Vilmann P, Sabbagh L, Wallace MB. EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc 2002; 55: 859-862.[PMID: 12024141]
64. DeWitt J, LeBlanc J, McHenry L, Ciaccia D, Imperiale T, Chappo J, Cramer H, McGreevy K, Chriswell M, Sherman S. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience. Am J Gastroenterol 2003; 98: 1976-1981.[PMID: 14499774]
65. Chang KJ, Albers CG, Nguyen P. Endoscopic ultrasound-guided fine needle aspiration of pleural and ascitic fluid. Am J Gastroenterol 1995; 90: 148-150.[PMID: 7801920]
66. Nguyen PT, Chang KJ. EUS in the detection of ascites andEUS-guided paracentesis. Gastrointest Endosc 2001; 54: 336-339.[PMID: 11522974]
67. DeWitt J, Yu M, Al-Haddad MA, Sherman S, McHenry L, Leblanc JK. Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA. Gastrointest Endosc 2010; 71: 260-265.[PMID: 19922924 DOI: 10.1016/j.gie.2009.08.025]
68. Pishvaian AC, Collins B, Gagnon G, Ahlawat S, HaddadNG. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc 2006; 64: 412-417.[PMID: 16923491 DOI:10.1016/j.gie.2006.01.048]
69. Sanders MK, Moser AJ, Khalid A, Fasanella KE, Zeh HJ, Burton S, McGrath K. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc 2010; 71: 1178-1184.[PMID: 20362284 DOI: 10.1016/j.gie.2009.12.020]
70. Park WG, Yan BM, Schellenberg D, Kim J, Chang DT, Koong A, Patalano C, Van Dam J. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc 2010; 71: 513-518.[PMID: 20189509 DOI: 10.1016/ j.gie.2009.10.030]
71. DiMaio CJ, Nagula S, Goodman KA, Ho AY, Markowitz AJ, Schattner MA, Gerdes H. EUS-guided fiducial placement for image-guided radiation therapy in GI malignancies by using a 22-gauge needle (with videos). Gastrointest Endosc 2010; 71: 1204-1210.[PMID: 20598247 DOI: 10.1016/j.gie.2010.01.003]
72. Ammar T, Coté GA, Creach KM, Kohlmeier C, Parikh PJ, Azar RR. Fiducial placement for stereotactic radiation by using EUS: feasibility when using a marker compatible with a standard 22-gauge needle. Gastrointest Endosc 2010; 71: 630-633.[PMID: 20189527 DOI: 10.1016/j.gie.2009.11.023]
73. Khashab MA, Kim KJ, Tryggestad EJ, Wild AT, Roland T, Singh VK, Lennon AM, Shin EJ, Ziegler MA, Sharaiha RZ, Canto MI, Herman JM. Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy. Gastrointest Endosc 2012; 76: 962-971.[PMID: 23078921 DOI:10.1016/j.gie.2012.07.006]
74. Jin Z, Chang KJ. Endoscopic ultrasound-guided fiducialmarkers and brachytherapy. Gastrointest Endosc Clin N Am 2012; 22: 325-31.[PMID: 22632954 DOI: 10.1016/ j.giec.2012.04.012]
75. Sun S, Xu H, Xin J, Liu J, Guo Q, Li S. Endoscopic ultra-sound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy 2006; 38: 399-403.[PMID: 16680642 DOI: 10.1055/s-2006-925253]
76. Jin Z, Du Y, Li Z, Jiang Y, Chen J, Liu Y. Endoscopicultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy 2008; 40: 314-320.[PMID: 18283622 DOI: 10.1055/s-2007-995476]
77. Du Y, Jin Z, Meng H, Zou D, Chen J, Liu Y, Zhan X, Wang D, Liao Z, Li Z. Long-term effect of gemcitabine-combined endoscopic ultrasonography-guided brachytherapy in pancreatic cancer. J Interv Gastroenterol 2013; 3: 18-24.[PMID: 24147222 DOI: 10.7178/jig.102]
78. Wang KX, Jin ZD, Du YQ, Zhan XB, Zou DW, Liu Y, Wang D, Chen J, Xu C, Li ZS. EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain control in pancreatic carcinoma: a prospective pilot study. Gastrointest Endosc 2012; 76: 945-952.[PMID: 22841501 DOI: 10.1016/j.gie.2012.05.032]
79. Wiersema MJ, Wiersema LM. Endosonography-guided ce-liac plexus neurolysis. Gastrointest Endosc 1996; 44: 656-662.[PMID: 8979053]
80. Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ. Aprospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc 2001; 54: 316-324.[PMID: 11522971]
81. Puli SR, Reddy JB, Bechtold ML, Antillon MR, Brugge WR. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci 2009; 54: 2330-2337.[PMID: 19137428 DOI: 10.1007/s10620-008-0651-x]
82. Yan BM, Myers RP. Neurolytic celiac plexus block for paincontrol in unresectable pancreatic cancer. Am J Gastroenterol 2007; 102: 430-438.[PMID: 17100960 DOI: 10.1111/ j.1572-0241.2006.00967.x]
83. Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev 2011; (3): CD007519.[PMID: 21412903 DOI: 10.1002/14651858.CD007519.pub2]
84. Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV. Ran-domized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol 2011; 29: 3541-3546.[PMID: 21844506 DOI: 10.1200/JCO.2010.32.2750]
85. Levy MJ, Topazian MD, Wiersema MJ, Clain JE, Rajan E, Wang KK, de la Mora JG, Gleeson FC, Pearson RK, Pelaez MC, Petersen BT, Vege SS, Chari ST. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block. Am J Gastroenterol 2008; 103: 98-103.[PMID: 17970834 DOI: 10.1111/j.1572-0241.2007.01607. x]
86. Doi S, Yasuda I, Kawakami H, Hayashi T, Hisai H, Irisawa A, Mukai T, Katanuma A, Kubota K, Ohnishi T, Ryozawa S, Hara K, Itoi T, Hanada K, Yamao K. Endoscopic ultrasoundguided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial. Endoscopy 2013; 45: 362-369.[PMID: 23616126 DOI: 10.1055/s-0032-1326225]
87. Fujii L, Clain JE, Morris JM, Levy MJ. Anterior spinal cordinfarction with permanent paralysis following endoscopic ultrasound celiac plexus neurolysis. Endoscopy 2012; 44 Suppl 2 UCTN: E265-E266.[PMID: 22814912 DOI: 10.1055/ s-0032-1309708]
88. Mittal MK, Rabinstein AA, Wijdicks EF. Pearls & amp;oysters: Acute spinal cord infarction following endoscopic ultrasound-guided celiac plexus neurolysis. Neurology 2012; 78: e57-e59.[PMID: 22371417 DOI: 10.1212/ WNL.0b013e318248df51]
89. Loeve US, Mortensen MB. Lethal necrosis and perforationof the stomach and the aorta after multiple EUS-guided celiac plexus neurolysis procedures in a patient with chronic pancreatitis. Gastrointest Endosc 2013; 77: 151-152.[PMID: 22624792 DOI: 10.1016/j.gie.2012.03.005]
90. Gimeno-García AZ, Elwassief A, Paquin SC, Sahai AV. Fatal complication after endoscopic ultrasound-guided celiac plexus neurolysis. Endoscopy 2012; 44 Suppl 2 UCTN: E267.[PMID: 22814913 DOI: 10.1055/s-0032-1309709]
91. Jang HY, Cha SW, Lee BH, Jung HE, Choo JW, Cho YJ, Ju HY, Cho YD. Hepatic and splenic infarction and bowel ischemia following endoscopic ultrasound-guided celiac plexus neurolysis. Clin Endosc 2013; 46: 306-309.[PMID: 23767046 DOI: 10.5946/ce.2013.46.3.306]
92. Chang KJ, Nguyen PT, Thompson JA, Kurosaki TT, Casey LR, Leung EC, Granger GA. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 2000; 88: 1325-1335.[PMID: 10717613]
93. Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, Kirn DH, Freeman SM. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003; 9: 555-561.[PMID: 12576418]
94. Irisawa A, Takagi T, Kanazawa M, Ogata T, Sato Y, Tak-enoshita S, Ohto H, Ohira H. Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study. Pancreas 2007; 35: 189-190.[PMID: 17632329 DOI:10.1097/01.mpa.0000250141.25639.e9]
95. Hanna N, Ohana P, Konikoff FM, Leichtmann G, Hubert A, Appelbaum L, Kopelman Y, Czerniak A, Hochberg A. Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer. Cancer Gene Ther 2012; 19: 374-381.[PMID: 22498722 DOI: 10.1038/ cgt.2012.10]
96. Herman JM, Wild AT, Wang H, Tran PT, Chang KJ, Taylor GE, Donehower RC, Pawlik TM, Ziegler MA, Cai H, Savage DT, Canto MI, Klapman J, Reid T, Shah RJ, Hoffe SE, Rosemurgy A, Wolfgang CL, Laheru DA. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol 2013; 31: 886-894.[PMID: 23341531 DOI: 10.1200/JCO.2012.44.7516]
97. Khashab MA, Dewitt J. EUS-guided biliary drainage: isit ready for prime time? Yes! Gastrointest Endosc 2013; 78: 102-105.[PMID: 23820411 DOI: 10.1016/j.gie.2013.03.004]
98. Nguyen-Tang T, Binmoeller KF, Sanchez-Yague A, Shah JN. Endoscopic ultrasound (EUS)-guided transhepatic anterograde self-expandable metal stent (SEMS) placement across malignant biliary obstruction. Endoscopy 2010; 42: 232-236.[PMID: 20119894 DOI: 10.1055/s-0029-1243858]
99. Artifon EL, Safatle-Ribeiro AV, Ferreira FC, Poli-de-Figueiredo L, Rasslan S, Carnevale F, Otoch JP, Sakai P, Kahaleh M. EUS-guided antegrade transhepatic placement of a self-expandable metal stent in hepatico-jejunal anastomosis. JOP 2011; 12: 610-613.[PMID: 22072253]
100. Kahaleh M, Hernandez AJ, Tokar J, Adams RB, Shami VM, Yeaton P. Interventional EUS-guided cholangiography: eval-uation of a technique in evolution. Gastrointest Endosc 2006; 64: 52-59.[PMID: 16813803 DOI: 10.1016/j.gie.2006.01.063]
101. Maranki J, Hernandez AJ, Arslan B, Jaffan AA, Angle JF, Shami VM, Kahaleh M. Interventional endoscopic ultrasound-guided cholangiography: long-term experience of an emerging alternative to percutaneous transhepatic cholangiography. Endoscopy 2009; 41: 532-538.[PMID: 19533558 DOI:10.1055/s-0029-1214712]
102. Kim YS, Gupta K, Mallery S, Li R, Kinney T, Freeman ML. Endoscopic ultrasound rendezvous for bile duct access using a transduodenal approach: cumulative experience at a single center. A case series. Endoscopy 2010; 42: 496-502.[PMID: 20419625 DOI: 10.1055/s-0029-1244082]
103. Fabbri C, Luigiano C, Fuccio L, Polifemo AM, Ferrara F, Ghersi S, Bassi M, Billi P, Maimone A, Cennamo V, Masetti M, Jovine E, D'Imperio N. EUS-guided biliary drainage with placement of a new partially covered biliary stent for palliation of malignant biliary obstruction: a case series. Endoscopy 2011; 43: 438-441.[PMID: 21271507 DOI: 10.1055/ s-0030-1256097]
104. Komaki T, Kitano M, Sakamoto H, Kudo M. Endoscopicultrasonography-guided biliary drainage: evaluation of acholedochoduodenostomy technique. Pancreatology 2011; 11 Suppl 2: 47-51.[PMID: 21464587 DOI: 10.1159/000323508]
105. Park do H, Jang JW, Lee SS, Seo DW, Lee SK, Kim MH. EUS-guided biliary drainage with transluminal stenting after failed ERCP: predictors of adverse events and long-term results. Gastrointest Endosc 2011; 74: 1276-1284.[PMID: 21963067 DOI: 10.1016/j.gie.2011.07.054]
106. Hara K, Yamao K, Niwa Y, Sawaki A, Mizuno N, Hijioka S, Tajika M, Kawai H, Kondo S, Kobayashi Y, Matumoto K, Bhatia V, Shimizu Y, Ito A, Hirooka Y, Goto H. Prospective clinical study of EUS-guided choledochoduodenostomy for malignant lower biliary tract obstruction. Am J Gastroenterol 2011; 106: 1239-1245.[PMID: 21448148 DOI: 10.1038/ ajg.2011.84]
107. Iwashita T, Lee JG, Shinoura S, Nakai Y, Park DH, Muth-usamy VR, Chang KJ. Endoscopic ultrasound-guided ren-dezvous for biliary access after failed cannulation. Endoscopy 2012; 44: 60-65.[PMID: 22127960 DOI: 10.1055/s-0030-1256871]
108. Shah JN, Marson F, Weilert F, Bhat YM, Nguyen-Tang T, Shaw RE, Binmoeller KF. Single-operator, single-session EUS-guided anterograde cholangiopancreatography in failed ERCP or inaccessible papilla. Gastrointest Endosc 2012; 75: 56-64.[PMID: 22018554 DOI: 10.1016/j.gie.2011.08.032]
109. Dhir V, Bhandari S, Bapat M, Maydeo A. Comparison ofEUS-guided rendezvous and precut papillotomy techniques for biliary access (with videos). Gastrointest Endosc 2012; 75: 354-359.[PMID: 22248603 DOI: 10.1016/j.gie.2011.07.075]
110. Park do H, Jeong SU, Lee BU, Lee SS, Seo DW, Lee SK, Kim MH. Prospective evaluation of a treatment algorithm with enhanced guidewire manipulation protocol for EUS-guided biliary drainage after failed ERCP (with video). Gastrointest Endosc 2013; 78: 91-101.[PMID: 23523301 DOI: 10.1016/ j.gie.2013.01.042]
111. Savides TJ, Varadarajulu S, Palazzo L. EUS 2008 WorkingGroup document: evaluation of EUS-guided hepaticogas-trostomy. Gastrointest Endosc 2009; 69: S3-S7.[PMID: 19179166 DOI: 10.1016/j.gie.2008.10.060]
112. Itoi T, Yamao K. EUS 2008 Working Group document:evaluation of EUS-guided choledochoduodenostomy (withvideo). Gastrointest Endosc 2009; 69: S8-12.[PMID: 19179177 DOI: 10.1016/j.gie.2008.11.003]
113. Artifon EL, Aparicio D, Paione JB, Lo SK, Bordini A, Rabello C, Otoch JP, Gupta K. Biliary drainage in patients with unre-sectable, malignant obstruction where ERCP fails: endoscopic ultrasonography-guided choledochoduodenostomy versus percutaneous drainage. J Clin Gastroenterol 2012; 46: 768-774.[PMID: 22810111 DOI: 10.1097/MCG.0b013e31825f264c]